Skip to main content

Table 7 Binary logistic regression for prediction of HCC in the studied groups

From: Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

IL-18 genotype Β P OR (95% CI)
CC B1 20.97 p1 1.0 OR1 undefined
B2 20.82 p2 1.0 OR2 undefined
B3 0.15 p3 0.92 OR3 1.17 (0.07–19.7)
GC B1 1.85 p1 0.09 OR1 6.33 (0.73–55.2)
B2 1.69 p2 0.13 OR2 5.43 (0.63–47.02)
B3 0.15 p3 0.79 OR3 1.17 (0.38–3.58)
GG (R)  
  1. This table shows that control patients with GC genotype have a risk for developing HCC and cirrhosis by 6.33- and 5.43-folds, respectively, more than those with GG genotype while cirrhotic patients with CC and GC genotype have a risk for developing HCC by 1.17-folds more than those with GG genotype
  2. Bl constant of regression equation of HCC versus control group, B2 constant of regression equation of cirrhosis versus the control group, B3 constant of regression equation of cirrhosis versus the HCC group, pl comparison of the control and HCC groups, p2 comparison of control and cirrhosis, p3 comparison of cirrhosis and HCC, OR odds ratio, CI confidence interval, R reference group